Cumberland Pharmaceuticals Reports Double Digit Revenue Growth For The Fourth Consecutive Quarter

Published: Aug 09, 2017

NASHVILLE, Tenn., Aug. 8, 2017 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced second quarter 2017 financial results with Net Revenues of $8.7 million, up 17% over the prior year quarter. It was the fourth consecutive quarter of year over year revenue growth for the Company, and during the first half of 2017 Net Revenues increased 21% over the prior year period.

Back to news